{
  "item1": "Components devices minimally invasive interventional surgical procedures, including cannulas, catheters medical balloons. Products also include proprietary single-use plastic components medical applications, including biopharmaceutical, patient care/surgical diagnostic systems. – Precision manual semi-automated dispensers highly engineered single-use plastic molded syringes, cartridges, tips fluid connection components. Products used within critical medical industrial production processes applying controlling flow adhesives, sealants lubricants.",
  "item7": "Item 7. Management's Discussion Analysis Financial Condition Results Operations NOTE REGARDING AMOUNTS FISCAL YEAR REFERENCES annual report, all amounts related United States dollars foreign currency number Nordson Corporation’s common shares, except per share earnings dividend amounts, expressed thousands. Unless context otherwise indicates, all references “we,” “us,” “our,” “Company” mean Nordson Corporation. Unless otherwise noted, all references years relate fiscal year ending October 31.",
  "item2": "f foreign currency losses. Included other-net nine months ended July 31, 2024 pension postretirement income $3,085 $2,411 foreign currency losses. record interim provision income taxes based estimated annual effective tax rate, well certain items discrete current period. Significant judgment involved regarding application global income tax laws regulations when projecting jurisdictional mix income."
}